| Term 
 | Definition 
 
        | Epinephrine: 0.5 mL of 1:100 soln; 0.5 mL of 11.25 mg soln in 2.25% saline (13.5 mg of Racepinephrine HCl USP) Brand Name: Adrenalin; Primatene Mist or Epinephrine CFC inhaler; cannot be made or sold after December 31, 2011; Asthmanefrin an alternative to Primatene (OTC); Epipen
 Actions:  Alpha, Beta 1 & Beta 2 Receptors
 Indications: Asthma and reversible bronchospasm in allergic reactions
 Dosing : 320 mcg per puff; 60-90 minute duration;
 Contraindications: Should be used with caution in cardiac patients or tachycardias; patients on MAOIs and tricyclic antidepressants
 Precautions: Protect from light
 Side Effects: Palpitations, anxiety,
 tremors, nausea and vomiting
 |  | 
        |  | 
        
        | Term 
 
        | Med Chemistry: Epinephrine |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ephedrine: 50 mg in water for injection; FDA banned in US in 2004 Brand Name: Claritin-D, Sudafed
 Actions:  Alpha, Beta 1 & Beta 2 Receptors
 Indications: Asthma and reversible bronchospasm in allergic reactions. Also used for appetite suppressant and stimulant
 Dosing : Similar to Epinephrine but weaker; 50mg/mL , IM, SC and IV with a longer duration > 90 min
 Contraindications: Should be used with caution in cardiac
 patients or tachycardias and not taken with
 certain antidepressants, namely SNRIs (serotonin-
 norepinephrine re-uptake inhibitors)
 Precautions: Protect from light
 Side Effects: Palpitations, anxiety,
 tremors, nausea and vomiting
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | phenethylamine alkaloid. Alkaloid 
 The CIP system or the R-S system was devised by three European chemists: R.S. Cahn, C.K. Ingold and V. Prelog to designate the configuration of chiral center of enantiomers
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Isoproterenol: 80-120 mcg via microaserosol, inhaled pressure canister(rarely used for asthma) Brand name: Isuprel HCl, Medihaler-Iso
 Actions:  60-90 min duration of action on Beta 1 & 2 Receptors
 Indications: Rarely used for Asthma due to its increased asthma mortality rate in the UK (mid-1960’s). Today use to manage bronchospasm during anesthesia and adjunctive treatment for shock
 Dosing: Maximal bronchodilation within 5 minutes; has a 60 to
 90 minute duration of action
 Contraindications: Cardiac arrhythmias associated
 with tachycardia
 Precautions: IV infusions have caused clinical
 deterioration and death
 Side Effects: Dizziness, BP changes,
 headaches, pulmonary edema,
 tremors, nausea and vomiting
 |  | 
        |  | 
        
        | Term 
 
        | Med Chemistry: Isoproterenol |  | Definition 
 
        | The β activity of isoproterenol is more enhanced over norepinephrine and epinephrine activity at the alpha (α) receptors decreases  and activity at the beta (β) receptors increases
 
 Due to CH2CH3 on R1
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Albuterol (Short Acting) Terbutaline (Short Acting)
 Metaproterenol(Short Acting)
 Pirbuterol( Short Acting)
 Salmeterol(Long Acting; partial agonist)
 Formoterol (Long Acting; full agonist)
 Indacaterol (Ultra-long acting; Approved in Europe only)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | World Health Organization recommended name: Salbutamol Albuterol sulfate: Inhalation aerosol at 80 and 200 inhalation; inhalation soln at 0.63, 1.25 and 2.5 mg/3mL, also 5mg/mL; Syrup: 2 mg/5mL; Tablets at 2,4 and 8 mg
 Brand Name: Proventil, Proventil-HFA, Ventolin, Volmax, Vospire, and ProAir
 Actions: Short acting (onset 5-15 min; duration 3-5 hr)  at the Beta 2 Receptors
 Indications: Asthma or exercise-induced asthma can
 also be
 used to treat patients with emphysema or chronic
 bronchitis
 Dosing: 1-2 inhalations q  4-6 h by aerosol; exercise-induced bronchospasm is 2 inhalation 15 min prior exercise. Nebulizer dose
 is 0.63 mg, 1.25 mg or 2.5 mg 3-4 times a day.
 Tablet dose or syrup is 2 or 4 mg given tid or
 qid
 Peak Plasma Time: Inhalation: 2-5 hr.; oral: 2-2.5 hr.
 Distribution: protein bound 10%
 Metabolism:  Liver
 Elimination: t1/2: 3-4 hr.; excretion: urine
 Contraindications: Should be used with caution in cardiac
 patients or tachycardias and not taken with
 certain antidepressants, namely SNRIs (serotonin-
 norepinephrine re-uptake inhibitors) MAOIs; beta-blocker i.e.,
 propranolol
 Precautions: Causes hypokalemia (low potassium)
 so combining with a loop diuretics i.e, furosomide
 (Lasix) may increase hypokalemia
 Side Effects: Palpitations, headaches
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | short-acting Beta 2 adrenergic agonist tertiary butyl group in salbutamol (or albuterol) makes it more selective for β2-receptors
 The drug is sold as a racemic mixture mainly because the (S)-enantiomer blocks metabolism pathways while the (R)-enantiomer shows activity.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Terbutaline is listed by the World Anti-Doping Agency (WADA) as a prohibited drug for Olympic athletes Terbutaline sulfate: Tablets: 2.5 and 5 mg. Injection: 1 mg/ml. Inhaler: 0.2 mg/puff. Nubulizer: 1 mg/ml.
 Brand name: Brethine, Bricanyl, Brethaire (All are no longer available in US)
 Actions:  Short acting on Beta 2 Receptors; inhalation:5 min; oral: 30 min
 Indications: is used to relieve and prevent bronchospasms caused by asthma, emphysema or bronchitis. It also is used for preventing preterm labor, a tocolytic agent
 Dosing: 2.5-5 mg 3 to 4 times daily approximately 6 hours apart
 while awake; subcutaneous, 0.2 mg q 15-30 minutes for two
 dose; inhaler, 2 puffs q 4-6 h; preterm labor, 2.5  to
 10 mcg/min via iv infusion. Typical effective dose is
 17.5-30 mcg/min and treatment should not exceed
 72 hours
 Peak Plasma Time: Inhalation: 2-5 hr.; oral: 2-2.5 hr.
 Distribution: protein bound 10%
 Metabolism:  Liver
 Elimination: Half-life (T1/2) – 3-4 hr.; excretion: urine
 Contraindications: Should be used with caution in cardiac
 patients or tachycardias and not taken with
 certain antidepressants, namely SNRIs (serotonin-
 norepinephrine re-uptake inhibitors) MAOIs; beta-blocker i.e.,
 propranolol
 Precautions: Causes hypokalemia (low potassium)
 so combining with a loop diuretics i.e, furosomide
 (Lasix) may increase hypokalemia
 Side Effects: Palpitations, headaches
 |  | 
        |  | 
        
        | Term 
 
        | Med Chemistry: Terbutaline |  | Definition 
 
        | short-acting β2 adrenergic agonist The tertiary butyl group in terbutaline makes it more selective for β2-receptors
 Since there is no hydroxy group on the 4 position of the benzene ring - the molecule is less susceptible to metabolism by Catechol-O-methyltransferase (COMT) enzyme
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | metaproterenol sulfate: Inhalation aerosol (100-200 puffs) at 0.65 mg/puff; inhalation soln at 0.4-0.6 % soln in 2.5 ml (contents contain 10-15 mg) also  in 5% soln; Syrup: 10 mg/5mL; Tablets at 10 and 20 mg Brand Name: Alupent, Metaprel
 Actions: Moderate selectivity at the Beta 2 Receptors and has significant Beta 1 Receptor activity (onset 5 min via inhalation; duration 2-6 hr)
 Indications: Bronchodilator for treatment of asthma and COPD (emphysema and bronchitis)
 Dosing: 2-3 inhalations q  3-4 h by aerosol (no more thatn 12 puff/day); Nebulizer dose: 0.01 mL/kg up to 0.3 mL 5% solution nebulized q 4-6hr; Tablet dose is
 20 mg given tid or qid; Syrup 10mg/5mL tid or
 qid
 Peak Plasma Time: 60 min
 Absorption: inhaled (3%)
 Metabolism: metabolized in liver and GI, major metobolite, metaproterenol-O-sulfate is produced in the GI; Orciprenaline is not metabolized by catechol-0-methyltransferase nor have glucuronide conjugates been isolated to date.
 Excretion: Half-life (T1/2) 6 hr; urine (40%)
 Contraindications: Should not taken with beta-blockers
 ie., propranolol;Theophylline may increase (toxicity);
 antidepressants (TCAs and MAOIs)
 Precautions: Causes hypokalemia
 Side Effects: Palpitations, headaches,
 arrhythmias
 |  | 
        |  | 
        
        | Term 
 
        | Med Chemistry: Metaproterenol |  | Definition 
 
        | Metaproterenol or oriprenaline is a direct acting resorcinol analog of isoproterenol The N-Isopropyl is Beta directing and the combination of the resorcinol ring system enhances the β2 selectivity
 short-acting β2 adrenergic agonist with some β1 activity
 It is the least potent of the β2, and this is most likely due of the poor β2 selectivity of isopropyl group
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pirbuterol inhalers will not be made, dispensed, or sold in the United States in their current form after December 31, 2013. The U.S. Food and Drug Administration (FDA) has set this final date for the medication in order to comply with the Montreal Protocol on Substances That Deplete the Ozone Layer. These inhalers contain chlorofluorocarbons (CFCs),chemicals that deplete the ozone layer 
 Pirbuterol acetate: (aerosol, metered, inhalation); Each 14.g canister provides 400 puffs and each 2.8 g canister provides 80 puffs; Each actuation delivers 253 mcg of pirbuterol (as pirbuterol acetate) from the valve and 200 mcg of pirbuterol (as pirbuterol acetate) from the mouthpiece.
 Brand Name: Maxiar (autohaler; breath-activated metered-dose inhaler)
 Actions: Short acting (onset < 5 min; duration 5 hr) at the Beta 2
 Receptors
 Indications: Acute asthma and COPD and maintenance
 Dosing: 1-2 actuations q 4-6hr PRN, no more than 12
 actuations/day
 Peak Plasma Time: Unknown; systemic blood levels of pirbuterol are below the limit of assay sensitive (2-5 ng/ml) following inhalation of doses up to 800 mcg (twice the maximum recommended dose)
 Absorption: Rapidly absorbed following aerosol administration
 Metabolism: unknown; not metabolized by catechol-O-methyltransferase.
 Excretion:Half-life (T1/2) 2 hr; urine (50%; pirbuterol + sulfate conjugate)
 Contraindications: Similar to albuterol; should not taken with beta-blockers ie., propranolol;  antidepressants (TCAs and MAOIs)
 Precautions: Causes hypokalemia
 Side Effects: Palpitations, headaches,
 arrhythmias
 |  | 
        |  | 
        
        | Term 
 
        | Med Chemistry: Pirbuterol |  | Definition 
 
        | an interesting analog of albuterol in which the benzene ring has been replaced by a pyridine ring 
 Similar to albuterol, pirbuterol is a selective β2 agonist available only for inhalation administration
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | (partial agonist) 
 Salmeterol (xinafoate): It is a long-acting beta-adrenoceptor agonist (LABA); micronized powder formulation administered via a breath-activated multidose powder inhaler (Diskus); double-foil blister strip of a powder formulation of salmeterol xinafoate for oral inhalation only. Each blister on the double-foil strip within the device contains 50 mcg of salmeterol; usually   administered concomitantly with inhaled corticosteroids,i.e., Fluticasone/salmeterol (Advair) or beclomethasone
 Brand Name: Serevent Diskus
 Actions: long acting (5 min; duration 12 hr) at the Beta 2 Receptors due to its lipid solubility
 Indications: COPD and exercise-induced bronchospasm, caution with patient with asthma (managed). Should not used for acute asthma
 or COPD have warning to caused
 asthma-related death
 Dosing: one inhalation twice daily with 12 hr between doses
 Peak Plasma Time: Does not predict therapeutic effects; Tmax= 20 min; mean Cmax = 167 pg/mL
 Absorption/Distribution: Rapidly absorbed following aerosol administration; 96 % protein bound
 Metabolism: Extensively metabolized by hydroxylation; Hepatic CYP3A4
 Excretion: Eliminated in feces (60%) and urine (25%); Half-life (T1/2) 5.5 days; Xinafoate moiety half-life is 11 days
 Contraindications: Use without a concomitant long-term asthma control medication (i.e.,, inhaled corticosteroid) for the treatment of asthma; hypersensitivity to salmeterol or product components; Similar to albuterol; should not taken with beta-blockers ie., propranolol;  antidepressants (TCAs and MAOIs);
 Precautions: Causes hypokalemia
 Side Effects: Palpitations, headaches, hypertension
 arrhythmias
 |  | 
        |  | 
        
        | Term 
 
        | Med Chemistry: Salmeterol |  | Definition 
 
        | Salmeterol has the same phenyl ring substituition R3 as albuterol but also an unusually long and lipophilic group R1 
 The octanol-water partition coefficient, log P for salmeterol is 3.88, compared with 0.66 for albuterol
 
 Salmeterol is approximately 50-fold more selective than albuterol for β2 receptor
 The long duration of action results from the specific binding interaction (‘anchoring”) of the phenyl group at the end of the  extended lipophilic side chain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | (Full agonist) 
 Formoterol : It is a long-acting beta-adrenoceptor agonist (LABA); marketed in four forms: a dry-powder inhaler (DPI), a metered-dose inhaler  (MDI), an oral tablet, and an inhalation solution; formoterol are used as "symptom controllers" to supplement prophylactic orticosteroid therapy (i.e., fluticasone). A "reliever" short-acting β2 agonist (i.e., salbutamol) is still required
 Brand Name: Under various trade names including Foradil/Foradile, Oxeze/Oxis, Atock, Atimos (Modulite), and Perforomist
 Actions: long acting (5 min; duration 12 hr) at the Beta 2 Receptors due to its lipid solubility
 Indications: COPD and exercise-induced bronchospasm, caution with patient with asthma (managed). Should not used for acute asthma
 or COPD have warning to caused
 asthma-related death
 Dosing: one inhalation (12 mcg inhalation capsule) twice daily with 12 hr between doses; one 20 mcg/2mL via nebulizer every 12 hr
 Peak Plasma Time: 92 pg/ml within 5 min of administration
 Absorption/Distribution: Rapidly absorbed following aerosol administration; 61-64% protein bound; Serum albumin binding was 31% to 38% over a range of 5 to 500 ng/mL
 Metabolism: Extensively metabolized by hepatic demethylation and glucuronidation; Hepatic CYP2D6, CYP2C19, CYP2C9 and CYP2A6 are involved
 Excretion: Eliminated via renal and fecal; Half-life (T1/2) 10 hours; Contraindications: Use without a concomitant long-term asthma control medication (i.e.,, inhaled corticosteroid) for the treatment of asthma; hypersensitivity to salmeterol or product components; Similar to albuterol; should not taken with beta-blockers ie., propranolol;  antidepressants (TCAs and MAOIs);
 Precautions: Causes hypokalemia
 Side Effects: Palpitations, headaches, hypertension
 arrhythmias
 |  | 
        |  | 
        
        | Term 
 
        | Med Chemistry: Formoterol |  | Definition 
 
        | Formoterol has 3’-formylamino and 4’-hydroxy ring R3 substituion pattern and an alkoxyphenylethyl lipophilic group R1 on the nitrogen 
 Formoterol is less lipophilic ( og P = 1.6) than salmeterol, it has a 12 hour duration of action similar to salmeterol
 
 It is unstable to heat and moisture therefore it is administered as an inhaled dry powder.
 It is a mixture of (R,R)-(-)- and (S,S)-(+)- stereoisomers with the (R, R)-isomer having 1000-fold more affinity for the β2 receptor than the (S,S)-isomer
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Theophylline is used to treat asthma (acute and chronic) Theophylline preparation commonly used is aminophylline, a theophylline-ethylenedimine complex
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Theobromine is 3.7-dimethyl xanthine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Major source is beverages i.e., tea cocoa and coffee, respectively
 Caffiene is 3.7- tri-
 methylxanthine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Methylxanthine have effects on the CNS, kidney, cardiac, skeletal muscle and smooth muscle 
 Theophylline is most selective in its smooth muscle effects
 
 Caffeine has a marked CNS effects
 
 In CNS: mild cortical arousal with increased alertness and deferral of fatigue, larger dose act as effective bronchodilator causing nervousness and tremor
 
 In Cardiovascular: has positive chronotropic and inotropics effect; low concentration inhibits adenosine receptor in sympathetic nerves, increase cardiac output, decrease blood viscosity
 
 In Gastrointestinal Tract: secretion of both gastric acid and digestive enzyme
 
 In Smooth Muscle: bronchodilation as the major therapeutic action in
 asthma; in sufficient concentration inhibits antigen-induced release
 of histamine
 |  | 
        |  | 
        
        | Term 
 
        | Med Chemistry: Methylxanthine |  | Definition 
 
        | methylxanthine differ by the position and number of methyl on their xanthine ring system Theophylline is 1.3-dimethylxanthine; adenosine antagonist; acts as an acid pka=8.6; metabolized by combination of C-8 oxidation and N-demethylation in liver; urinary metabolite, 1,3 dimethyl uric acid(product of the action xanthine oxidase)
 |  | 
        |  | 
        
        | Term 
 
        | Clinical Uses Anti-Muscarinic Agents |  | Definition 
 
        | Inhalation of the modified prototypical antimuscranic, atropine which is a selective quaternary ammonium derivative, ipratropium bromide (Atrovent) are effective  in bronchodilation and partial inhibition of provoked bronchospasm 
 The modified atropine, Ipratropium bromide delivered in high dose is poorly absorbed into circulation and does not enter CNS and the degree of PNS varies among patients
 
 Effective in patients with COPD resulting in a partial reversibility rather than patient with asthma
 
 A longer acting, selective antimuscarinc agent, tiotropium (Spriva or Cipla), is approved for Tx of COPD
 
 It binds to M1, M2 and M3 receptor with equal affinity; taken via inhalation at a single dose of 18 mcg with 24 hour duration; reduce COPD exacerbation and has been approved by FDA as a treatment for COPD
 
 It has not been approved for Tx of asthma but has been shown to be as
 effective as the addition of long-acting Beta-agonist insufficiently
 controlled by inhaled corticosteroid therapy alone
 |  | 
        |  | 
        
        | Term 
 
        | Clinical Uses Corticosteroids Agents |  | Definition 
 
        | MOA: Anti-inflammatory properties; they do not relax airway smooth muscle but reduce reactivity and reduce their frequency of asthma exacerbation; inhibition of inflitrates by lymphocytes, eosinophils and mast cells in asthmatic airway 
 Clinical use to improve all indices of asthma control, severity of symptoms and bronchial reactivity, exacerbations and quality of life
 
 Aerosol Tx is the most effective way to avoid systemic adverse effects
 
 Beclomethasone, budesonide, ciclesonide, flnisolide, flticasone, mometasone and triamcinolne deliver to airway with minimum systemic absorption
 
 Side effect of inhaled topical corticosteroid is oropharyngeal candidiasis
 
 Ciclesonide is a prodrug, and becomes activated by cleavage
 By esterase in bronchial cells. When absorbed the active product is
 tightly serum bound minimizing risk of toxicity
 
 Inhaled corticosteroid are properly labeled as “controller,”
 they are effective as long as taken
 |  | 
        |  | 
        
        | Term 
 
        | Clinical Uses Cromolyn and Nedocromil Agents |  | Definition 
 
        | MOA: Cromolyn and nedrocromil alter the function of delayed chloride channels in the cell membranes, inhibiting cell acivation Cromolyn sodium (disodium cromoglycate) and nedrocromil widely used Tx for asthma management and have low solubility, poor absorption from the GI tract
 Nedocromil has low bioavailability and is only available in meter-dose aerosol
 Inhalation of microfine powder or microfine suspension; effectively inhibits both  antigen and exercise-induced asthma and chronic use (four times daily)
 Have no effects on airway smooth  muscle tone and are ineffective in reversing asthmatic  bronchospasm. Only valuable when taken prophylactically
 |  | 
        |  | 
        
        | Term 
 
        | Clinical Uses Leukotriene Pathway Inhibitors Agents |  | Definition 
 
        | MOA: Interrupint the leukotriene pathway by inhibiting 5-lipoxygenase and inhibiting binding of LTD4 to its receptor target tissue Efficacy in blocking airway responses to exercise and to antigen challenge has been observed in both categories zileuton, a 5-lipoxygenase inhibitor, and zafirlukast and montelukast, LTD4-recptor antagonists
 All improve asthma control and reduce the frequency of asthma exacerbations
 Advantage is that they can be taken orally especially when complying to inhaled therepies is poor
 Zileuton is least prescribed because of reported liver toxicity and montelukast most prescribed due to its once-daily treatment and can be taken without meals.
 |  | 
        |  | 
        
        | Term 
 
        | Anti-IgE Monoclonal Antibodies |  | Definition 
 
        | Anti-IgE Monoclonal Antibodies: monoclonal antibody targeted against the portionof IgE that binds to its receptor (FCε-RI and FCε-R2 receptors) on mast cells and other inflammatory cells Omalizumab, inhibits the binding of IgE on mast cells but does not activate IgE already bound to these cells thus not allowing mast cell degranulation
 Administration of Omalizumab reduces IgE levels and lessens asthma severity and reduces corticosteroid requirement
 Reduce the frequency and severity of asthma exacerbations
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Smoke Cessation Studies (colloquially quitting smoking) the process of discontinuing the practice of inhaling a smoked substance
 Cigarette smoke is the major risk factor for COPD and chronic lower respiratory
 diseases like asthma, bronchitis and emphysema.
 Nicotine is a drug in tobacco that is addictive. It is rapidly absorbed in the airway epithelium and 1mg of nicotine is absorbed from each cigarette
 Methods that have been found to be effective include interventions
 directed at or via health care providers and health care systems;
 medications including nicotine replacement therapy (NRT) and
 varenicline (nicotine partial agonist); bupropion
 (nicotine antagonist) individual and group counseling;
 and Web-based programs.
 |  | 
        |  |